- Abstract:
-
The intracellular distribution of Auger electron-emitting radiopharmaceuticals is a determinant of cytotoxicity. However, the mechanisms by which these agents are routed through the cell are ill understood. The aim of this study was to investigate how trafficking of (111)In-labeled human epidermal growth factor ((111)In-DTPA-hEGF) relates to that of the EGF receptor (EGFR) and whether coadministration of agents that modulate EGFR signaling alters the efficacy of (111)In-DTPA-hEGF.The spatiote...
Expand abstract - Publication status:
- Published
- Peer review status:
- Peer reviewed
- Publisher:
- Society of Nuclear Medicine Publisher's website
- Journal:
- Journal of nuclear medicine : official publication, Society of Nuclear Medicine Journal website
- Volume:
- 52
- Issue:
- 5
- Pages:
- 776-783
- Publication date:
- 2011-01-01
- DOI:
- EISSN:
-
1535-5667
- ISSN:
-
0161-5505
- URN:
-
uuid:87c1b803-5a1a-4028-9303-1452aa39e9b9
- Source identifiers:
-
134951
- Local pid:
- pubs:134951
- Language:
- English
- Keywords:
- Copyright holder:
- Society of Nuclear Medicine
- Copyright date:
- 2011
Journal article
ErbB-2 blockade and prenyltransferase inhibition alter epidermal growth factor and epidermal growth factor receptor trafficking and enhance (111)In-DTPA-hEGF Auger electron radiation therapy.
Actions
Authors
Funding
Cancer Research
UK
More from this funder
Medical Research Council
More from this funder
CRUK/EPSRC Oxford Cancer Imaging Centre
More from this funder
National Institute for Health Research Oxford Biomedical
Research Centre
More from this funder
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record